This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One in five cultivators have voluntarily surrendered their licenses this year. SupplyChain Woes Further up the supplychain, distributors are also buckling under. One in five cannabis cultivators in California have voluntarily surrendered their licenses this year. A year later, less than a thousand remain.
With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”. New progressive regulation on cannabis in Colombia.
This export also validates the emergence of the global cannabinoid sector with reliance on quality, traceability and sustainability that Avicanna ’s Aureus products offer. To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.
In this guide, we’re exploring the intricate journey of the medical marijuana cultivation process including distribution, various techniques, regulations, and trends shaping the industry. Medical Marijuana Cultivation Process The journey of medical marijuana begins with cultivation.
CBD and other cannabinoids are fast becoming (if not already) household names. The industry consensus is that the total THC requirement is impractical and likely devastating to cultivators and, therefore, to every business in the hemp supplychain. And for good reason: the recreational market is expanding. Hemp is legal.
This burgeoning industry encompasses a wide range of activities, including cultivation, processing, distribution, and retail sales of medical cannabis products. The establishment of cultivation, processing, and dispensary facilities creates a diverse array of employment opportunities, spanning from agricultural roles to retail positions.
This transaction will enable Comfort Leaf to launch operations as a growing Direct-to-Consumer wellness-focused cannabinoid company. Comfort Leaf’s direct-to-customer platform will enable the delivery of high-quality hemp-derived cannabinoid products at unprecedented prices. as Strategic Advisors. “We
Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor industrial hemp cultivation in China’s only legalized province for cannabinoid extraction. “The partnership with CBDer is the first major step of our expansion into China.
In April, New Jersey regulators declined to renew Curaleaf’s lucrative adult-use cannabis license, citing the layoffs following the closure of one of its cultivation facilities, as well as the company’s clash with unions and lack of transparency. Sponsored by CannaCraft, Inc., Sponsored by CannaCraft, Inc.,
This certification is a key component of Flora’s global supplychain strategy and distribution plan as it enables cannabinoid and non-cannabinoid containing cosmetic products to be produced at its facility in Colombia for brands under its Flora Beauty division, as well as for white-label clients. Phytotherapeutics.
Less than a month after debuting on the Nasdaq Stock Market, Colombia-based cultivator Flora Growth is connecting its cannabis pipeline to Europe through a manufacturing and distribution partnership with Hoshi International. Flora Growth cultivates 100 hectares of cannabis year-round near the equator in Bucaramanga, Columbia. .
The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI), and First November Group, recently announced the launch of a new wide-ranging commission to review regulation and public policy in the United Kingdom’s (UK) legal cannabis industry called the Hodges Review.
New regulations position Colombia’s cultivators as leaders to supply the global cannabis market; dried cannabis flower continues to account for an estimated 50% of demand in major international markets, including US, Germany, and Australia (1). Colombian Cannabis Cultivation. per gram of dried flower. With over 12.5
Italy does not require an authorisation for cultivation and does not penalise growers if their crops exceeds 0.2 While cultivation of hemp from EU certified seeds is legal in all 28 Member States, requirements, THC limits, and permitted purposes differ from country to country. Licensed cultivators deliver the harvest to the Ministry.
DCC needs to present a report to the Governor by July 1, 2022 that outlines the steps necessary for the incorporation of hemp products (and cannabis products with hemp cannabinoids) into the cannabis supplychain. AB 141 – Meet the Department of Cannabis Control. The California cannabis market is headed for a real change.
(“Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.
is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. About VEXT Science, Inc. Vext Science, Inc. Based in Arizona , Vext Science, Inc.
Existing law governs the cultivation of industrial hemp in this state and establishes a registration program administered by county agricultural commissioners and the Department of Food and Agriculture for growers of industrial hemp, hemp breeders, and established agricultural research institutions, as defined.
Flora Growth said these new regulations will allow for the opportunity to increase near-term revenue and optimize its global diversified supplychain of premium brands and products.
Hemp-CBD intended to be consumed or absorbed into the human body must also be tested under New York’s medical marijuana program for “cannabinoid profile, solvents, pesticides, heavy metals, bacteria and molds.” The dietary supplement standards are in addition to THC testing for CBD products.
Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. cannabinoid hemp and hemp extract.”
The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supplychain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.
(the “ Company ” or “ Aurora “) (NASDAQ: ACB ) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Aurora Nederland B.V., Growery”), one of the few license holders entitled to participate in the Controlled Cannabis SupplyChain Experiment (the “CCSC”).
Flora Lab, Flora Growth’s wholly-owned GMP-certified manufacturing facility, will be responsible for producing the cannabinoid-infused products for the JV, with an emphasis on incorporating cannabidiol (“CBD”) into its product formulations. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. founder and CEO of Avaria. “Our
is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Refreshing all natural flavors, sparkling with the essence of tempting fruit.
Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.
New regulations position Colombia’s cultivators as leaders to supply the global cannabis market; dried cannabis flower continues to account for an estimated 50% of demand in major international markets, including U.S., Colombian Cannabis Cultivation. Germany and Australia. per gram (or roughly $27 per pound) of dried flower.
New regulations position Colombia’s cultivators as leaders to supply the global cannabis market; dried cannabis flower continues to account for an estimated 50% of demand in major international markets, including U.S., Colombian Cannabis Cultivation. Germany and Australia. per gram (or roughly $27 per pound) of dried flower.
Chair of Clinical Pharmacology, University of Newcastle; Director of the NHMRC-funded Australia Centre for Cannabinoid Clinical and Research Excellence (ACRE). ” To mark the launch, we are pleased to announce our new Editorial Advisory Board.
The supplychain of our group of companies makes an excellent addition to the enormous dynamism of SynBiotic SE,” Kruse said. SynBiotic SE researches, develops and produces cannabinoid-based products. The vertically integrated company’s operations span cultivation, production and retail sales. Blue-chip acquisitions.
The weakness relates to the collection and remittance of Cannabis Excise Tax [“CET”] and Cannabis Cultivation Tax [“CCT”]. The Distributor is the “choke” point in the supplychain. You must collect the cultivation tax from cultivators when the cannabis enters the commercial market based on weight and category of the cannabis.
Cannabidiol or CBD is a natural cannabinoid that actively affects the human body. Such companies focus on organic cannabis cultivation, making sure that their products are eco-friendly. The previously forbidden plant is gaining incredible popularity. And all thanks to the latest medical research. Moreover, the effect is curative.
Driven by their mission to set a new hemp standard, LUXEARI’s expert staff manages the entire supplychain so they can truly stand by what they sell. The company’s organic farm cultivates thriving sun-grown hemp using purity-tested water from the Rocky Mountains. Tantalizing self-care. Courtesy of LUXEARI.
Just as with the previous proposal, those Registered Organizations would be permitted to vertically integrate their business and would not be subject to the prohibition of adult-use cultivators, processors and/or distributors having a financial stake in a retail dispensary. Adult-Use Licenses.
After three full years of hemp cultivation, Linda Noel was confident 2021 would be a success. The cultivation season is quickly approaching, and producers like Noel are left to decide whether to grow based only on the hope that regulations will be administered in time. SEE MORE: 2020 Hemp Cultivation Data By State.
Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.
Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.
Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.
Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.
TORONTO and RIONEGRO, Colombia , June 15, 2021 /CNW/ – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO ) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S.,
Just as with the previous proposal, those Registered Organizations would be permitted to vertically integrate their business and would not be subject to the prohibition of adult-use cultivators, processors and/or distributors having a financial stake in a retail dispensary. Adult-Use Licenses.
New regulations position Colombia’s cultivators as leaders to supply the global cannabis market; dried cannabis flower continues to account for an estimated 50% of demand in major international markets, including U.S., Colombian Cannabis Cultivation. Germany and Australia. per gram (or roughly $27 per pound) of dried flower.
(TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. Global SupplyChain Platform.
A distributor may label or re-label manufactured cannabis goods but only for the purpose of properly stating the amount of cannabinoids and terpenoids contained in the cannabis products based on the results of regulatory compliance testing.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content